3,396 CME Group Inc. $CME Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd reduced its holdings in CME Group Inc. (NASDAQ:CME) by 5.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 58,645 shares of the financial services provider’s stock after selling 3,396 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in CME Group were worth $15,364,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CME. BlackRock Inc. acquired a new stake in CME Group during the 2nd quarter worth $6,749,965,000. Bank of America Corp DE raised its position in shares of CME Group by 39.1% during the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock valued at $1,187,290,000 after acquiring an additional 1,130,587 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of CME Group during the 2nd quarter valued at $867,313,000. Alphabet Inc. bought a new stake in shares of CME Group during the 2nd quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of CME Group in the 2nd quarter valued at $629,771,000. 87.75% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO Terrence Duffy sold 15,000 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the completion of the transaction, the chief executive officer owned 40,630 shares of the company’s stock, valued at $11,150,497.20. The trade was a 26.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elizabeth Cook sold 500 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the sale, the director owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by company insiders.

CME Group Stock Up 0.6%

Shares of NASDAQ CME opened at $295.31 on Wednesday. The stock has a market cap of $106.19 billion, a P/E ratio of 25.05, a P/E/G ratio of 3.79 and a beta of 0.24. The firm has a 50 day moving average price of $275.44 and a 200 day moving average price of $270.55. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.96 earnings per share. Analysts expect that CME Group Inc. will post 12.30 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Analyst Ratings Changes

Several research firms have recently issued reports on CME. The Goldman Sachs Group reduced their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. JPMorgan Chase & Co. lifted their price objective on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Piper Sandler dropped their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and cut their target price for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Finally, Wall Street Zen raised CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 3rd. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $292.94.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Analysts expect third-quarter revenue of approximately $1.71 billion, up 11.4% year over year, with EPS forecasts near $2.98. International trading volume reportedly rose 22%, and several analysts have raised their price targets ahead of the report. CME earnings preview
• Positive Sentiment: CME launched Bitcoin Cash and Uniswap futures, including standard and micro contracts, expanding its regulated cryptocurrency derivatives offering and potentially creating additional trading and clearing revenue. CME Bitcoin Cash and Uniswap futures
• Positive Sentiment: The planned launch of cash-settled tungsten futures in the first half of 2027 gives CME another avenue for growth in metals and critical-minerals trading, where volumes have been strong. The product remains subject to regulatory approval. CME tungsten futures
• Positive Sentiment: Investors are examining whether CME’s market-data operations can make earnings more stable and less reliant on temporary surges in trading activity, supporting the company’s recurring-revenue profile. CME market-data analysis
• Neutral Sentiment: The CFTC asked a federal court to dismiss CME’s lawsuit concerning cryptocurrency perpetual futures. The agency’s reliance on CME data may support the exchange’s market expertise, but the legal dispute and regulatory uncertainty remain unresolved. CFTC CME perpetual-futures lawsuit
• Neutral Sentiment: CME disclosed $460,000 in third-quarter lobbying focused on derivatives regulation, clearinghouses, Treasury futures, digital-asset legislation and tax policy. Institutional ownership changes were mixed, while the median recent analyst price target was $305. CME lobbying and ownership update
• Negative Sentiment: Recent insider activity was weighted toward selling, including multiple sales by Chairman and CEO Terrence Duffy. Falling lumber futures, driven by higher interest rates and seasonal weakness, also point to softer conditions in one CME-traded market, although the direct effect on company earnings is limited. Lumber futures outlook

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.